Subcutaneous Trastuzumab for HER2-positive Breast Cancer - Evidence and Practical Experience in 7 German Centers.
Geburtshilfe Frauenheilkd
; 75(6): 566-573, 2015 Jun.
Article
in En
| MEDLINE
| ID: mdl-26166837
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Clinical_trials
Language:
En
Journal:
Geburtshilfe Frauenheilkd
Year:
2015
Document type:
Article
Country of publication:
Alemania